Coriolis Pharma extends its service portfolio by integrating RheaVita’s single vial unit (SVU) technology for continuous and controlled freeze-drying to stabilize novel modalities as part of biologics drug product development for clients.

Newsletter Q1 2023

Research at Ghent University, in collaboration with The University of British Columbia, has shown that continuous freeze-drying of mRNA LNPs enables long-term storage at higher temperatures for months without losing their transfection properties

On March 14 & 15 we attended the Advanced Therapies Congress in London where we presented a new poster on avoiding cold chain logistic challenges by using freeze-drying to stabilize gene therapies.

Stay up to date with the latest scientific insights

RheaVita will participate in the 7th Commercializing Continuous Processing in Pharma Summit in Boston.